Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEARL2: High-Dose Ranibizumab in Polypoidal Choroidal Vasculopathy
NCT01884597Phase 2Completed
- Sponsor
- Hawaii Pacific Health
- Start
- Nov 2010
- Primary completion
- Aug 2014
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab in polypoidal choroidal vasculopathy (PCV), sponsored by Hawaii Pacific Health. Started Nov 2010; status: completed.
02
Drugs
ranibizumab
03
Conditions
polypoidal choroidal vasculopathy (PCV)
Beyond the preview
Go deeper on NCT01884597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01884597.